QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents

Elnaz Habibpour1, Shahin Ahmadi2

  • 1Department of Chemistry, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.

Abstract

Insights

Genetic-Algorithm-based Multiple Linear Regression (GA-MLR) proved superior to stepwise MLR for developing quantitative structure-activity relationship (QSAR) models of anticancer agents. This approach aids in designing more potent arylthioindole derivatives by identifying key structural features influencing activity.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Cancer remains a significant global health threat, driving the search for novel therapeutic agents.
  • Natural products like colchicine and vinblastine target microtubule assembly, inhibiting cancer cell proliferation.
  • Quantitative Structure-Activity Relationship (QSAR) modeling is crucial for understanding drug-receptor interactions and designing new drugs.

Purpose of the Study:

  • To develop QSAR models for arylthioindole derivatives as anticancer agents targeting colchicine polymerization.
  • To compare the efficacy of Genetic Algorithm-MLR (GA-MLR) and stepwise MLR (S-MLR) in QSAR modeling.
  • To identify key structural features of arylthioindoles responsible for anticancer activity.

Main Methods:

  • Utilized a dataset of 49 arylthioindole compounds with experimental inhibition values.
  • Generated and reduced 1185 molecular descriptors to 447, eliminating low-correlation and collinear variables.
  • Applied GA-MLR and S-MLR techniques to training and external validation sets for model development.

Main Results:

  • Both GA-MLR and S-MLR identified optimal QSAR models with five parameters.
  • External validation showed a Q2test value of 0.6209 for GA-MLR and 0.1144 for S-MLR.
  • GA-MLR demonstrated superior performance in variable selection and predictive accuracy.

Conclusions:

  • GA-MLR is a more powerful method than S-MLR for variable selection in QSAR studies.
  • Arylthioindole derivatives with higher electron density at the C2 position exhibit greater anticancer potency (IC50).
  • These findings can guide the synthesis of more effective anticancer agents.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K